{"id":7643,"date":"2025-02-26T09:56:56","date_gmt":"2025-02-26T06:56:56","guid":{"rendered":"https:\/\/www.sakiaivsb.lt\/?p=7643"},"modified":"2025-02-26T09:56:57","modified_gmt":"2025-02-26T06:56:57","slug":"pacientams-taps-prieinami-nauji-vaistai-nuo-vezio","status":"publish","type":"post","link":"https:\/\/www.sakiaivsb.lt\/?p=7643","title":{"rendered":"Pacientams taps prieinami nauji vaistai nuo v\u0117\u017eio"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Privalomojo sveikatos draudimo fondo (PSDF) biud\u017eeto l\u0117\u0161omis bus kompensuojama vienuolika nauj\u0173 vaist\u0173, skirt\u0173 \u012fvairi\u0173 form\u0173 v\u0117\u017eiui gydyti. Vaistini\u0173 preparat\u0173 ir medicinos pagalbos priemoni\u0173 kompensavimo komisija naujus vaistus si\u016blo prad\u0117ti kompensuoti nuo baland\u017eio 1 d.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201e\u012e kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161us perkeliami visi vaistiniai preparatai, kurie iki \u0161iol buvo rezerviniame s\u0105ra\u0161e ir lauk\u0117 finansavimo. Tai gera \u017einia \u0161imtams pacient\u0173, kuriems \u0161ie naujovi\u0161ki ir efektyv\u016bs vaistai pad\u0117s suvaldyti onkologines ligas, pagerinti gyvenimo kokyb\u0119 ir netgi visi\u0161kai pasveikti. Ministerija deda visas pastangas, kad inovatyv\u016bs vaistai kuo grei\u010diau pasiekt\u0173 Lietuvos pacientus ir b\u016bt\u0173 u\u017etikrintas jiems reikalingas finansavimas\u201c, \u2013 teigia sveikatos apsaugos viceministras Daniel Naumovas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">I\u0161 rezervinio vaist\u0173 s\u0105ra\u0161o \u012f kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161us perkeliami \u0161ie vaistiniai preparatai:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>darolutamidas, skirtas prostatos v\u0117\u017eiui gydyti;<\/li>\n\n\n\n<li>pembrolizumabas, skirtas gimdos kaklelio v\u0117\u017eiui gydyti;<\/li>\n\n\n\n<li>daunorubicinas su citarabinu, skirti \u016bminei mieloidinei leukemijai gydyti;<\/li>\n\n\n\n<li>pembrolizumabas, skirtas stempl\u0117s ir gastroezofagin\u0117s jungties v\u0117\u017eiui gydyti;<\/li>\n\n\n\n<li>trastuzumabo derukstekanas, tukatinibas, olaparibas, abemaciklibasir sacituzumabo govitekanas, skirti kr\u016bties v\u0117\u017eiui gydyti.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Vaistai pradedami kompensuoti tik po to, kai j\u0173 registruotojai pasira\u0161o sutartis su Valstybine ligoni\u0173 kasa. Jeigu tai bus padaryta laiku ir visi min\u0117ti vaistai bus prad\u0117ti kompensuoti nuo baland\u017eio 1 d., \u0161iemet jiems bus skirta papildomai 19 mln. eur\u0173 PSDF biud\u017eeto l\u0117\u0161\u0173.<\/p>\n\n\n\n<p class=\"has-text-align-right wp-block-paragraph\"><a href=\"https:\/\/sam.lrv.lt\/lt\/struktura-ir-kontaktine-informacija\/kontaktai-ziniasklaidai\/\" target=\"_blank\" rel=\"noreferrer noopener\"><em>SAM Komunikacijos skyrius<\/em><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Privalomojo sveikatos draudimo fondo (PSDF) biud\u017eeto l\u0117\u0161omis bus kompensuojama vienuolika nauj\u0173 vaist\u0173, skirt\u0173 \u012fvairi\u0173 form\u0173 v\u0117\u017eiui gydyti. Vaistini\u0173 preparat\u0173 ir medicinos pagalbos priemoni\u0173 kompensavimo komisija naujus vaistus si\u016blo prad\u0117ti kompensuoti nuo baland\u017eio 1 d. \u201e\u012e kompensuojam\u0173j\u0173 vaist\u0173 s\u0105ra\u0161us perkeliami visi vaistiniai preparatai, kurie iki \u0161iol buvo rezerviniame s\u0105ra\u0161e ir lauk\u0117 finansavimo. Tai gera \u017einia \u0161imtams [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":7644,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-7643","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-naujienos"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.sakiaivsb.lt\/index.php?rest_route=\/wp\/v2\/posts\/7643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sakiaivsb.lt\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sakiaivsb.lt\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sakiaivsb.lt\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sakiaivsb.lt\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7643"}],"version-history":[{"count":1,"href":"https:\/\/www.sakiaivsb.lt\/index.php?rest_route=\/wp\/v2\/posts\/7643\/revisions"}],"predecessor-version":[{"id":7645,"href":"https:\/\/www.sakiaivsb.lt\/index.php?rest_route=\/wp\/v2\/posts\/7643\/revisions\/7645"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sakiaivsb.lt\/index.php?rest_route=\/wp\/v2\/media\/7644"}],"wp:attachment":[{"href":"https:\/\/www.sakiaivsb.lt\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7643"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sakiaivsb.lt\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7643"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sakiaivsb.lt\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}